PanGen Biotech Inc. (KOSDAQ:222110)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,000.00
-70.00 (-1.15%)
Last updated: May 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Contract Manufacturing Organization (CMO)
5.65B
Log In
Log In
Log In
Log In
Contract Manufacturing Organization (CMO) Growth
254.46%
Log In
Log In
Log In
Log In
EPO Medicine
5.64B
Log In
Log In
Log In
Log In
EPO Medicine Growth
65.43%
Log In
Log In
Log In
Log In
Royalty
1.15B
Log In
Log In
Log In
Log In
Royalty Growth
324.85%
Log In
Log In
Log In
Log In
Technology Transfer (CDO)
623.13M
Log In
Log In
Log In
Log In
Technology Transfer (CDO) Growth
-35.69%
Log In
Log In
Log In
Log In
Other
1.61B
Log In
Log In
Log In
Log In
Other Growth
50.30%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
South Korea
8.87B
Log In
Log In
Log In
Log In
South Korea Growth
90.53%
Log In
Log In
Log In
Log In
Overseas
5.81B
Log In
Log In
Log In
Log In
Overseas Growth
118.17%
Log In
Log In
Log In
Log In